P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19

• S. Kayser,
• D. Martínez-Cuadrón,
• R. Rodriguez-Veiga,
• M. Hänel,
• M. Tormo,
• K. Schäfer-Eckart,
• C. Botella,
• F. Stölzel,
• T. Bernal del Castillo,
• U. Keller,
• C. Rodriguez-Medina,
• G. Held,
• M.-L. Amigo,
• C. Schliemann,
• M. Colorado,
• M. Kaufmann,
• M. Barrios Garcia,
• S. W. Krause,
• M. Görner,
• E. Jost,
• B. Steffen,
• A. D. Ho,
• C. Baldus,
• H. Serve,
• U. Platzbecker,
• C. Müller-Tidow,
• C. Thiede,
• M. Bornhäuser,
• P. Montesinos,
• C. Röllig,
• R. F. Schlenk

Affiliations

S. Kayser

1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig

D. Martínez-Cuadrón

3 Hematology Department, 3HemaHospital Universitari i Politècnic, La Fe, Valencia

R. Rodriguez-Veiga

5 Hematology Department, Hospital Universitari i Politècnic, La Fe, Valencia, Spain

M. Hänel

6 Klinikum Chemnitz, Chemnitz, Germany

M. Tormo

7 Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, University of Valencia, Valencia, Spain

K. Schäfer-Eckart

8 Hospital Nord, Nürnberg, Germany

C. Botella

9 Hospital General, Alicante, Spain

F. Stölzel

10 Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany

T. Bernal del Castillo

11 Hospital Central de Asturias, Asturias, Spain

U. Keller

12 Department of Hematology, Oncology and Tumor Immunology, Charité-University Medical Center, Campus Benjamin Franklin, Berlin, Germany

C. Rodriguez-Medina

13 Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain

G. Held

14 Westpfalz Klinikum, Kaiserslautern, Germany

M.-L. Amigo

15 Hospital General Universitario Morales Meseguer, Murcia, Spain

C. Schliemann

16 University Hospital Muenster, Münster, Germany

M. Colorado

17 16Hospital Universitario Marqués de Valdecilla, Santander, Spain

M. Kaufmann

18 Robert Bosch Hospital Stuttgart, Stuttgart, Germany

M. Barrios Garcia

19 Department of Hematology, 18DepartmentHospital Regional Universitario de Málaga, Malaga, Spain

S. W. Krause

20 Department of Internal Medicine 5 – Hematology/Oncology, 19Department of Internal Medicine 5 – HeUniversity Hospital of Erlangen, Erlangen

M. Görner

21 Klinik für Hämatologie, Onkologie und Palliativmedizin, Klinikum Bielefeld Mitte, Bielefeld

E. Jost

22 University Hospital Aachen, Aachen

B. Steffen

23 Department of Internal Medicine II, Department oUniversity Hospital of Frankfurt Main, Frankfurt am Main

A. D. Ho

24 Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg

C. Baldus

25 Department of Internal Medicine II, University Hospital of, Kiel

H. Serve

26 Department of Internal Medicine II, 22Department of InterUniversity Hospital of Frankfurt Main, Frankfurt am Main

U. Platzbecker

1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig

C. Müller-Tidow

24 Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg

C. Thiede

27 Department of Medicine I, 9DepartmUniversity Hospital Carl-Gustav-Carus

M. Bornhäuser

28 Department of Medicine I, 9DepUniversity Hospital Carl-Gustav-Carus, Dresden

P. Montesinos

4 CIBERONC, Instituto Carlos III, Madrid

C. Röllig

10 Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany

R. F. Schlenk

24 Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg